LMAT News and Press, LeMaitre Vascular Inc. From 06/24/22

LeMaitre has been beaten down lately, however, the pullback lends significant opportunity to add to a long-term compounder. The company has a differentiated value proposition from an investment perspective and operates within a niche segment. We've priced LMAT at $52 per share on ...

BURLINGTON, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Sidoti Summer Small Cap Virtual Conference on Wednesday, June 15, 2022, at 2:30 PM ET. LeMaitre is a provider of devices, impla...

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...

The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with this event. For further details see: LeMaitre Vascular (LMAT) Investor presentations - Slideshow

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...

LeMaitre Vascular, Inc. (LMAT) Q1 2022 Earnings Conference Call April 28, 2022 17:00 ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer Dave Roberts - President Conference Call Participants Zach Weiner - Jefferies Brooks O&...

LeMaitre (LMAT) -4% on reporting Q2 EPS of $0.27 missing consensus by 1 cent. Sales of $39.6M, +10% was driven by Artegraft, XenoSure, carotid shunts, allografts and valvulotomes. By geography, sales were driven by the Americas (+12%), EMEA (+6%) and APAC (+9%). Gross margin decline...

LeMaitre Vascular press release (NASDAQ:LMAT): Q1 GAAP EPS of $0.27 misses by $0.01. Revenue of $39.56M (+10.3% Y/Y) beats by $0.91M. Q2 2022 Guidance - Sales of $40.1M - $42.1M 2022 Full Year Guidance - Sales of $160.0M - $164.0.M vs. consensus estimate of $164.73M For further details...

BURLINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q1 2022 Financial Results Sales of $39...

BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same ...